Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

News

Poll: Enteral Nutrition Therapy

02/14/2019

Advertisement

Advertisement

Advertisement

Advertisement

Sign up for our e-Newsletters

Gastroenterology Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

News

News
MASLD Identified as Osteoarthritis Risk Marker in US Adults
05/03/2024

Jolynn Tumolo

Jolynn Tumolo
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated steatotic liver disease was consistently associated with osteoarthritis across a variety of subgroups, researchers found.
Metabolic dysfunction-associated...
05/03/2024
Gastroenterology
fecal calprotectin test
News
Fecal Calprotectin: Effective Marker In Understanding Progression of Crohn's Disease
04/23/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of fecal calprotectin to better understand the trajectory of Crohn's disease.
Evidence shows the value of...
04/23/2024
Advances in Inflammatory Bowel Disease Network
Bharati Kochar
Conference Coverage
Bharati Kochar, MD, on Comparative Effectiveness in Positioning Therapies in Ulcerative Colitis
04/10/2024
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about considering the efficacy-safety relationship to avoid longstanding corticosteroid use or the use of less effective agents in biologic-exposed populations at the AIBD regional meeting in Boston.
Dr Bharati Kochar talks about...
04/10/2024
Advances in Inflammatory Bowel Disease Network
News
Biomarker Study Finds ‘Clearcut’ Case for Early Advanced Therapy for CD
04/08/2024

Jolynn Tumolo

Jolynn Tumolo
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly outperforms step-up treatment for Crohn’s disease with fewer adverse events.
Top-down therapy significantly...
04/08/2024
Advances in Inflammatory Bowel Disease Network
News
IBS Prevalence Slightly Above 6% in Pandemic-Era US Survey
03/28/2024

Jolynn Tumolo

Jolynn Tumolo
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed had not sought medical care for their IBS symptoms during the previous year.
Almost half of those surveyed...
03/28/2024
Gastroenterology
News
Extended Mirikizumab Induction Benefits Slower Responders in UC Trials
03/20/2024

Jolynn Tumolo

Jolynn Tumolo
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week induction period generated response in half of patients.
LUCENT trials found that 24-week...
03/20/2024
Advances in Inflammatory Bowel Disease Network
News
H. Pylori Infection Studied for Association With Colorectal Cancer
03/12/2024

Jolynn Tumolo

Jolynn Tumolo
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter pylori can alter the gut microbiome—and may drive development of colonic tumors.
Investigators find Helicobacter...
03/12/2024
Gastroenterology
News
Metabolic Health Does Not Protect Against Erosive Esophagitis in Adults With Obesity
03/08/2024

Jolynn Tumolo

Jolynn Tumolo
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body mass index were associated with higher risks of developing erosive esophagitis.
Waist circumference, higher body...
03/08/2024
Gastroenterology
News
Shared Gut Dysbiosis in Crohn’s Disease, Spondyloarthritis, & Acute Anterior Uveitis
03/06/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
The gut microbiome represents a promising avenue to understand shared and distinct pathophysiology among patients with immune-mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders.
The gut microbiome represents a promising avenue to understand shared and distinct pathophysiology among patients with immune-mediated diseases highly concomitant with nonmusculoskeletal inflammatory disorders.
The gut microbiome represents a...
03/06/2024
Gastroenterology
News
Intrarectal Injections of BoNTA for Fecal Incontinence?
03/04/2024

Priyam Vora, Associate Editor

Priyam Vora, Associate Editor
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate the efficacy of intrarectal botulinum toxin type A for the treatment of fecal incontinence in a randomized study. What did they find?
Researchers aimed to evaluate...
03/04/2024
Gastroenterology

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement